SGRY Surgery Partners Inc
Price (delayed)
$21.48
Market cap
$2.74B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.33
Enterprise value
$6.13B
Surgery Partners is headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for
Highlights
The gross profit has grown by 15% year-on-year and by 6% since the previous quarter
The revenue has grown by 14% YoY and by 4.3% from the previous quarter
SGRY's EPS has plunged by 183% from the previous quarter
The net income has dropped by 177% since the previous quarter
Key stats
What are the main financial stats of SGRY
Market
Valuations
Earnings
Shares outstanding
127.61M
Market cap
$2.74B
Enterprise value
$6.13B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.53
Price to sales (P/S)
0.87
EV/EBIT
36.47
EV/EBITDA
17.05
EV/Sales
1.97
Revenue
$3.11B
Gross profit
$745.6M
Operating income
$334.4M
Net income
-$168.1M
EBIT
$168.2M
EBITDA
$359.7M
Free cash flow
$212.3M
Per share
Balance sheet
Liquidity
EPS
-$1.33
EPS diluted
-$1.33
Free cash flow per share
$1.68
Book value per share
$14.08
Revenue per share
$24.69
TBVPS
$22.01
Total assets
$7.89B
Total liabilities
$4.69B
Debt
$3.66B
Equity
$1.79B
Working capital
$495M
Debt to equity
2.05
Current ratio
1.79
Quick ratio
1.36
Net debt/EBITDA
9.43
Margins
Efficiency
Dividend
EBITDA margin
11.5%
Gross margin
23.9%
Net margin
-5.4%
Operating margin
10.7%
Return on assets
-2.2%
Return on equity
-8.8%
Return on invested capital
3.2%
Return on capital employed
2.3%
Return on sales
5.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SGRY stock price
How has the Surgery Partners stock price performed over time
Intraday
-1.65%
1 week
1.23%
1 month
-11.2%
1 year
-13.53%
YTD
1.46%
QTD
-9.56%
Financial performance
How have Surgery Partners's revenue and profit performed over time
Revenue
$3.11B
Gross profit
$745.6M
Operating income
$334.4M
Net income
-$168.1M
Gross margin
23.9%
Net margin
-5.4%
The net income has dropped by 177% since the previous quarter
SGRY's net margin has shrunk by 170% QoQ
The gross profit has grown by 15% year-on-year and by 6% since the previous quarter
The revenue has grown by 14% YoY and by 4.3% from the previous quarter
Growth
What is Surgery Partners's growth rate over time
Valuation
What is Surgery Partners stock price valuation
P/E
N/A
P/B
1.53
P/S
0.87
EV/EBIT
36.47
EV/EBITDA
17.05
EV/Sales
1.97
SGRY's EPS has plunged by 183% from the previous quarter
The stock's price to book (P/B) is 60% less than its 5-year quarterly average of 3.9 and 14% less than its last 4 quarters average of 1.8
The equity has declined by 10% year-on-year and by 6% since the previous quarter
The P/S is 32% below the 5-year quarterly average of 1.3 and 27% below the last 4 quarters average of 1.2
The revenue has grown by 14% YoY and by 4.3% from the previous quarter
Efficiency
How efficient is Surgery Partners business performance
Surgery Partners's ROE has plunged by 184% from the previous quarter
SGRY's return on assets has dropped by 175% since the previous quarter
SGRY's ROIC is down by 18% YoY but it is up by 3.2% from the previous quarter
SGRY's ROS is down by 18% YoY but it is up by 3.8% from the previous quarter
Dividends
What is SGRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SGRY.
Financial health
How did Surgery Partners financials performed over time
The total assets is 68% greater than the total liabilities
Surgery Partners's total liabilities has increased by 22% YoY and by 6% QoQ
The total assets is up by 15% year-on-year and by 4.7% since the previous quarter
SGRY's debt is 105% higher than its equity
The debt to equity has grown by 35% YoY and by 12% from the previous quarter
SGRY's debt is up by 21% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.